Most Organizations Aren’t Built to Absorb What They are Being Asked to Do

keynote-hero

Most high-stakes initiatives don’t stall because the strategy was wrong or the technology failed.

Initiatives lose momentum. Pilots don't scale. Resistance gets misread—and the real problem stays invisible.

I'm useful in the room because I'm not in it the rest of the year—no turf to protect, just what I actually see, translated into what to do Monday morning. That view comes from senior roles at Citi, American Express and AXA, my work preparing technology leaders at Columbia University, and an LP stake in an early-stage fund evaluating emerging technologies firsthand.

Who Benefits Most

  • Leaders accountable for initiatives that aren't moving—pilots approved, investments made, progress stalled
  • Cross-Functional Decision Makers in Marketing, Technology, Strategy, and Sales who are trying to build alignment across teams that don't share language or incentives
  • Organizations at Critical Inflection Points where the pressure to scale AI or transformation is real, but the organizational readiness to absorb it isn't
  • Industries with Complex Stakeholder Dynamics including Financial Services, Insurance, and Technology

My sessions resonate most with senior and executive-level audiences who need to move from diagnosis to shared clarity—and who suspect the real problem runs deeper than the usual explanations.

keynote-2
keynote-3

What Audiences Gain

  • Clearer diagnosis: Leaders leave knowing which capability gaps are actually slowing progress—not symptoms, but root causes
  • Shared language: A common vocabulary that travels across functions, so alignment doesn't require another meeting to re-establish
  • Confidence to act: Because when you can finally see what's in the way, the path forward becomes visible
  • Reframed resistance: A different way of reading pushback—as information about where capability gaps live, not as obstacles to overcome

Popular Topics

Trust Has Gone Local: The Middle Management Crisis

Middle managers are expected to execute strategy, act as trust brokers in an environment of low trust and record employee disengagement, and absorb every workplace shock—under operating conditions still in place from a different era. 

Reframing Resistance: Turning Opposition into Your Greatest Asset

The standard response to resistance is to push harder. The better response is to treat it as diagnostic intelligence—what it's actually telling you, and what to do with it. 

Changing How We Change: Finding Allies, Building Momentum, and Making Change Stick

Mapping stakeholder landscapes and building engagement strategies that create momentum for sustainable business results.

Custom topics available addressing your audience's specific transformation priorities.

Presentation Formats

  • Keynote Addresses: 30-60 minute presentations with optional Q&A
  • Executive Roundtables: Focused sessions for senior leadership teams working through a specific transformation challenge
  • Fireside Chats & Panels: Conversational formats for interactive engagement
  • Workshops: Interactive sessions for deeper exploration

All formats available for in-person or virtual delivery.

dots-4
The cover of Amy radin's manifesto, What Makes a Change Maker a Change Maker?

Before “AI transformation” became a category, I was studying a different question: why some ideas move—and others stall.

Bring this into the room

If something important isn’t moving, this is where the conversation starts.

Contact Amy Radin

For keynote and leadership event inquiries, please contact Rachel Sales

Download My Speaker Sheet

View speaker profile

Advisory Services

Follow / Connect

Amy has fought many innovation battles on the front lines. 

Her stories bring to life the importance of not accepting traditional organizational push-back and how bravery and persistence really make innovation come alive. Amy keeps the audience fully engaged and furiously scribbling notes.

Dan Seewald
Founder & CEO, The Deliberate Innovator; Former Global Team Lead; Worldwide Innovation at Pfizer

Quote